Drugs / Octenisept
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04172363 | Jul 2020 → May 2021 | decubitus ulcer | RWTH Aachen University | Withdrawn | No outcome recorded |
Also used as a comparator or background therapy in 3 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT01434914 Comparator | Oct 2011 → Jul 2013 | ulcer of lower limbs | Schülke & Mayr GmbH | Terminated | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT07500844 Comparator | Feb 2023 → Nov 2025 | periodontal disorder | Research Centre for Medical Genetics, Russian Federation | Completed | No outcome recorded |
| — | NCT04325685 Comparator | Jan 2020 → Dec 2021 | acute respiratory distress syndrome, brain injury, encephalitis, epilepsy +3 | Northern State Medical University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Octenisept | “Antiseptic (Octenisept) group” NCT04325685 ↗ |
| Route | Topical | “Cutaneous solution” NCT01434914 ↗ |